北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 胃肠肿瘤中心  > 期刊论文
学科主题: 临床医学
题名:
The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries
作者: Sun, Guo-ping; Sun, Yan; Xu, Rui-hua; Xu, Jian-Ming; Li, Jin; Wang, Jin-Wan; Qin, Shukui; Feng, Ji Feng; Ba, Yi; Shen, Lin; Bai, Yu-Xian; Sun, Yihong; Pan, Hongming; Cheng, Ying; Yu, Shiying; Zhong, Haijun; Bai, Li; Luo, Rongcheng; Kobayashi, Mikiro; Ohtsu, Atsushi
刊名: JOURNAL OF CLINICAL ONCOLOGY
发表日期: 2013-05-20
卷: suppl.S, 期:15
收录类别: SCI ; ISTP
文章类型: Meeting Abstract
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
语种: 英语
WOS记录号: WOS:000335419601482
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/56149
Appears in Collections:北京大学临床肿瘤学院_胃肠肿瘤中心_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
2.Beijing 301 PLA Hosp, Beijing, Peoples R China
3.Guangzhou Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
4.GSK Japan Tokyo Head Off, Tokyo, Japan
5.Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
6.Jilin Prov Canc Hosp, Changchun, Peoples R China
7.Tongji Hosp, Ctr Oncol, Wuhan, Peoples R China
8.An Hui Med Univ, Affiliated Hosp 1, Dept Oncol, Hefei, Peoples R China
9.Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
10.Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
11.Acad Mil Med Sci, Hosp 307, Ctr Canc, Beijing, Peoples R China
12.Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
13.Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
14.Nanjing Bayi Hosp, PLA Canc Ctr, Nanjing, Jiangsu, Peoples R China
15.Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
16.Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
17.Peking Univ, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp, Beijing 100871, Peoples R China
18.Harbin Med Univ, Tumor Hosp, Harbin, Peoples R China
19.Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China
20.Shao Yifu Hosp, Hangzhou, Zhejiang, Peoples R China

Recommended Citation:
Sun, Guo-ping,Sun, Yan,Xu, Rui-hua,et al. The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries[J]. JOURNAL OF CLINICAL ONCOLOGY,2013,suppl.S(15).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Sun, Guo-ping]'s Articles
[Sun, Yan]'s Articles
[Xu, Rui-hua]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Sun, Guo-ping]‘s Articles
[Sun, Yan]‘s Articles
[Xu, Rui-hua]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace